ReviewCurrent pharmaceutical biotechnology2025
Potential Pathogens Associated with Colorectal Cancer.
Review in Current pharmaceutical biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut Bacteria: A Beneficial Symbiosis or a Hidden Threat? Investigating the Dual Role of Bacteria in Gastrointestinal Diseases.Current microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Colorectal Cancer (CRC) is a malignancy in which the cells of the colon and rectum grow uncontrollably. This disease initially appears as an adenomatous polyp, which, over time, turns into an advanced adenoma with high-grade dysplasia and becomes the basis of invasive cancer. Dysbiosis refers to the reduction of microbial diversity and disruption of the balance in the population of beneficial (microbiota) and harmful (pathogenic) microorganisms. The disruption of the balance causes an increase in pathogenic microbial species, which play a role in creating a pro-inflammatory environment. Therefore, dysbiosis can disrupt the balance of the microbiota population, leading to Gastrointestinal (GI) disorders like cancer. According to research, it has been established that certain pathogenic bacteria, specifically
Indexed as
Identifiers
41626679What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.